Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metabolism of Methylphenidate and Enalapril Based on CES1 Genotype
NCT02135263Phase 4Completed
- Sponsor
- Bispebjerg and Frederiksberg Hospital
- Start
- Apr 2012
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of methylphenidate, enalapril in attention deficit hyperactivity disorder (ADHD), hypertension (HTN), sponsored by Bispebjerg and Frederiksberg Hospital. Started Apr 2012; status: completed.
02
Drugs
methylphenidateenalapril
03
Conditions
attention deficit hyperactivity disorder (ADHD)hypertension (HTN)
Beyond the preview
Go deeper on NCT02135263.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02135263.